Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zilomole for progressive myopia in children
IRCT20250922067322N1Phase 2Recruiting
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of dorzolamide and timolol in myopia (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoint: Rate of change in refractive error. Started Jan 2026; status: recruiting.
02
Drugs
dorzolamidetimolol
03
Conditions
myopia
Beyond the preview
Go deeper on IRCT20250922067322N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250922067322N1.